Industry Analysis & Industry Trends
The Biotechnology industry is expected to generate revenue of £7.52 billion in 2012-13, up 3.4% on 2011-12. A young industry, biotechnology has only just reached overall profitability, with a slowly expanding number of firms reaping the rewards of past investment into commercialising biotech products. However, there remain many young firms that are enduring losses as they invest in research and development in the early stages of bringing products to market. IBISWorld estimates that industry revenue will increase at an annualised 3.9% over the five years through 2012-13.
The essential nature of many of the industry's products, like those for the human health market, has meant that the financial crisis has had only a minimal effect on industry revenue... purchase to read more
Industry Report - Industry Investment Chapter
The level of investment required is determined by comparing the human and capital equipment factors of production, using wages and depreciation costs as proxies. Comparatively high depreciation costs are indicative of a high level of investment in depreciable assets such as buildings and equipment, and therefore high capital intensity. Conversely, comparatively high wages costs indicate high labour intensity.
The industry relies on the application of knowledge by highly skilled staff in the research and development of biotech products... purchase to read more